NGM Biopharmaceuticals, Inc. SG&A Expenses 2019-2023 | NGM
NGM Biopharmaceuticals, Inc. sg&a expenses from 2019 to 2023. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
| NGM Biopharmaceuticals, Inc. Annual SG&A Expenses (Millions of US $) |
|
|---|---|
| 2023 | $38 |
| 2022 | $41 |
| 2021 | $37 |
| 2020 | $27 |
| 2019 | $24 |
| 2018 | $17 |
| 2017 | $15 |
| NGM Biopharmaceuticals, Inc. Quarterly SG&A Expenses (Millions of US $) |
|
|---|---|
| 2023-12-31 | $8 |
| 2023-09-30 | $9 |
| 2023-06-30 | $10 |
| 2023-03-31 | $12 |
| 2022-12-31 | $10 |
| 2022-09-30 | $10 |
| 2022-06-30 | $10 |
| 2022-03-31 | $11 |
| 2021-12-31 | $9 |
| 2021-09-30 | $9 |
| 2021-06-30 | $10 |
| 2021-03-31 | $9 |
| 2020-12-31 | $7 |
| 2020-09-30 | $6 |
| 2020-06-30 | $7 |
| 2020-03-31 | $7 |
| 2019-12-31 | $6 |
| 2019-09-30 | $6 |
| 2019-06-30 | $6 |
| 2019-03-31 | $5 |
| 2018-12-31 | $5 |
| 2018-09-30 | $5 |
| 2018-06-30 | $3 |
| 2018-03-31 | $4 |
